Study on activity of interleukin-6, C-reactive protein and alpha-2 macroglobulin in psoriatic patients during the acute clinical stage and remission.
Chodorowska
G
G
Katedra i Klinika Dermatologii Akademii Medycznej w Lublinie.
Czelej
D
D
Borowiec
M
M
Pietrzak
A
A
Krasowska
D
D
Kowal
M
M
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D015415:Biomarkers / Q000097:blood; D002097:C-Reactive Protein / Q000378:metabolism*; D006801:Humans; D015850:Interleukin-6 / Q000097:blood*; D008297:Male; D008875:Middle Aged; D011701:PUVA Therapy; D011237:Predictive Value of Tests; D011565:Psoriasis / Q000097:blood* / Q000628:therapy; D012074:Remission Induction; D000511:alpha-Macroglobulins / Q000378:metabolism*
D015415:Biomarkers; D015850:Interleukin-6; D000511:alpha-Macroglobulins; D002097:C-Reactive Protein